Actinium Pharmaceuticals, Inc. (ATNM)
AMEX·Healthcare·Biotechnology
$1.49
+3.85%
Mkt Cap $37.44M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$11.07
Range $4.00 – $24.26
Implied Upside
+645.5%
Consensus $11.07 vs current $1.49
AMEX·Healthcare·Biotechnology
$1.49
+3.85%
Mkt Cap $37.44M
No recent rating data.
Price Target (3 analysts)
$11.07
Range $4.00 – $24.26
+645.5%
Consensus $11.07 vs current $1.49